肾盂输尿管连接部梗阻性肾积水患儿术后尿路感染特点及防治策略

谢起根, 李作青, 苏诚, 等. 肾盂输尿管连接部梗阻性肾积水患儿术后尿路感染特点及防治策略[J]. 临床泌尿外科杂志, 2018, 33(4): 306-309. doi: 10.13201/j.issn.1001-1420.2018.04.014
引用本文: 谢起根, 李作青, 苏诚, 等. 肾盂输尿管连接部梗阻性肾积水患儿术后尿路感染特点及防治策略[J]. 临床泌尿外科杂志, 2018, 33(4): 306-309. doi: 10.13201/j.issn.1001-1420.2018.04.014
XIE Qigen, LI Zuoqing, SU Cheng, et al. Prevalence and treatment of urinary tract infection in children following pyeloplasty[J]. J Clin Urol, 2018, 33(4): 306-309. doi: 10.13201/j.issn.1001-1420.2018.04.014
Citation: XIE Qigen, LI Zuoqing, SU Cheng, et al. Prevalence and treatment of urinary tract infection in children following pyeloplasty[J]. J Clin Urol, 2018, 33(4): 306-309. doi: 10.13201/j.issn.1001-1420.2018.04.014

肾盂输尿管连接部梗阻性肾积水患儿术后尿路感染特点及防治策略

详细信息
    通讯作者: 李作青,E-mail:364818768@qq.com
  • 中图分类号: R726.9

Prevalence and treatment of urinary tract infection in children following pyeloplasty

More Information
  • 目的:探讨肾盂输尿管连接部梗阻(UPJO)性肾积水患儿术后尿路感染的特点及防治策略。方法:对2010年1月~2015年12月我院收治的498例输尿管连接部(UPJ)成形术患儿术前术后均行尿常规、尿细菌培养检查,分析总结术后尿路感染率、病原体分布及药敏结果、抗生素使用情况、住院或门诊治疗率。结果:肾积水术后尿常规阳性率为71.1%,尿培养阳性率为30.1%,尿路感染率为31.7%。从150份尿培养阳性患儿尿液中共检出168份菌株,其中杆菌占80.4%,球菌占15.5%,真菌占4.2%。大肠杆菌(45.8%)、铜绿假单孢菌(13.7%)、肺炎克雷伯杆菌(9.52%)是肾积水术后尿路感染最常见的三大病原体。耐药菌感染占26.8%,机会致病菌感染占40.4%。非限制使用级抗生素使用率90.2%,限制使用级抗生素使用率为12.2%,特殊使用级抗生素使用率为13.5%。因尿路感染住院治疗率为9.64%,门诊治疗率20.9%。结论:肾积水术后尿路感染较为复杂,发生率高,耐药菌及机会致病菌感染比例高。一、二代头孢耐药率高,怀疑有感染和存在感染的高危因素应果断选用高级别抗生素。
  • 加载中
  • [1]

    O'Reilly P H, Brooman P J, Mak S, et al.The long-term results of Anderson-Hynes pyeloplasty[J].BJU Int, 2001, 87 (4):287-289.

    [2]

    Fedelini P, Verze P, Meccariello C, et al.Intraoperative and postoperative complications of laparoscopic pyeloplasty:a single surgical team experience with 236cases[J].J Endourol, 2013, 27 (10):1224-1229.

    [3]

    Hao P, Li W, Song C, et al.Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases:report of 2685cases[J].J Endourol, 2008, 22 (1):65-70.

    [4]

    Ciftci H, Akin Y, Savas M, et al.Functional Result of Laparoscopic Pyeloplasty in Children:Single Institute Experience in Long Term[J].Urol Int, 2016, 97 (2):148-152.

    [5]

    Paz A, Amiel G E, Pick N, et al.Febrile Complications Following Insertion of 100 Double-J Ureteral Stents[J].J Endourol, 2005, 19 (2):147-150.

    [6]

    Sutherland R W, Chung S K, Roth D R, et al.Pediatric pyeloplasty:outcome analysis based on patient age and surgical technique[J].Urology, 1997, 50 (6):963-966.

    [7]

    Autorino R, Eden C, El-Ghoneimi A, et al.Robot-assisted and Laparoscopic Repair of Ureteropelvic Junction Obstruction:A Systematic Review and Meta-analysis[J].Eur Urol, 2014, 65 (2):430-452.

    [8]

    Aydin H R, Irkilata L, Aydin M, et al.Incidence of bacterial colonisation after indwelling of double-J ureteral stent[J].Ital Urol Androl, 2016, 87 (4):291-294.

    [9]

    García-Aparicio L, Blázquez-Gómez E, Martin O, et al.Bacterial characteristics and clinical significance of ureteral double-J stents in children[J].Actas Urol Esp, 2015, 39 (1):53-56.

    [10]

    Uvin P, Van Baelen A, Verhaegen J, et al.Ureteral stents do not cause bacteria infections in children after ureteral reimplantation[J].Urology, 2011, 78 (1):154-158.

    [11]

    Stefaniuk E, Suchocka U, Bosacka K, et al.Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland[J].Eur J Clin Microbiol Infect Dis, 2016, 35 (18):1363-1369.

    [12]

    Lob S H, Nicolle L E, Hoban D J, et al.Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014[J].Diagn Microbiol Infect Dis, 2016, 85 (4):459-465.

    [13]

    Butler C C, O'Brien K, Wootton M, et al.Empiric antibiotic treatment for urinary tract infection in preschool children:susceptibilities of urine sample isolates[J].Fam Pract, 2016, 33 (2):127-132.

    [14]

    Hertz F B, Nielsen J B, Schonning K, et al.Population structure of drug susceptible, resistant and ESBL-producing Escherichia coli from community-acquired urinary tract[J].BMC Microbiol, 2016, 16 (1):63-63.

    [15]

    Chen P C, Chang L Y, Lu C Y, et al.Drug susceptibility and treatment response of common urinary tract infection pathogens in children[J].J Microbiol Immunol Infect, 2014, 47 (6):478-483.

    [16]

    Picozzi S C, Casellato S, Rossini M, et al.Extendedspectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection:Urologist should act in time[J].Urol Ann, 2014, 6 (2):107-112.

    [17]

    Ironmonger D, Edeghere O, Gossain S, et al.Use of antimicrobial resistance information and prescribing guidance for management of urinary tract infections:survey of general practitioners in the West Midlands[J].BMC Infect Dis, 2016, 16:226-226.

    [18]

    Toner L, Papa N, Aliyu S H, et al.Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections:incidence and antibiotic susceptibility profile over 9years[J].World J Urol, 2016, 34 (7):1031-1037.

    [19]

    Ferroni M C, Lyon T D, Rycyna K J, et al.The Role of Prophylactic Antibiotics After Minimally Invasive Pyeloplasty With Ureteral Stent Placement in Children[J].Urology, 2016, 89:107-111.

  • 加载中
计量
  • 文章访问数:  245
  • PDF下载数:  696
  • 施引文献:  0
出版历程
收稿日期:  2017-01-06

目录